Auron Healthcare GmbH
π©πͺGermany
Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Auron Healthcare GmbH
- Target Recruit Count
- 73
- Registration Number
- NCT00405873
- Locations
- π©πͺ
University Hospital Freiburg, Dept. of Internal Medicine II, Freiburg im Breisgau, Baaden-Wuerttemberg, Germany
π©πͺClinic SanaFontis, Freiburg im Breisgau, Germany
Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Auron Healthcare GmbH
- Target Recruit Count
- 67
- Registration Number
- NCT00405561
- Locations
- π©πͺ
Clinic SanaFontis, Freiburg im Breisgau, Germany
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
Phase 2
Terminated
- Conditions
- Gastrointestinal CancerProstate CancerGenital Neoplasms, Female
- Interventions
- First Posted Date
- 2006-06-01
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Auron Healthcare GmbH
- Target Recruit Count
- 67
- Registration Number
- NCT00332280
- Locations
- π§π¦
Klinicki Centar Univerziteta Sarajevo - Klinika za gastroenterohepatologiju, Sarajevo, Bosnia and Herzegovina
π©πͺClinic SanaFontis, Freiburg im Breisgau, Germany
Β© Copyright 2025. All Rights Reserved by MedPath